Amalgamated Bank’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $32.5M | Sell |
64,872
-3,575
| -5% | -$1.72M | 0.22% | 64 |
|
|
2026
Q1 | $33.6M | Sell |
68,447
-1,353
| -2% | -$734K | 0.26% | 57 |
|
|
2025
Q4 | $40.4M | Sell |
69,800
-1,914
| -3% | -$1.08M | 0.29% | 45 |
|
|
2025
Q3 | $34.8M | Sell |
71,714
-1,221
| -2% | -$568K | 0.25% | 61 |
|
|
2025
Q2 | $29.6M | Sell |
72,935
-1,507
| -2% | -$630K | 0.23% | 71 |
|
|
2025
Q1 | $37M | Buy |
74,442
+995
| +1% | +$539K | 0.32% | 44 |
|
|
2024
Q4 | $38.2M | Sell |
73,447
-2,207
| -3% | -$1.21M | 0.31% | 43 |
|
|
2024
Q3 | $46.8M | Sell |
75,654
-1,499
| -2% | -$887K | 0.39% | 34 |
|
|
2024
Q2 | $42.7M | Sell |
77,153
-5,450
| -7% | -$3.12M | 0.36% | 34 |
|
|
2024
Q1 | $48M | Sell |
82,603
-12,236
| -13% | -$6.87M | 0.41% | 32 |
|
|
2023
Q4 | $50.3M | Sell |
94,839
-5,161
| -5% | -$2.5M | 0.4% | 35 |
|
|
2023
Q3 | $50.6M | Sell |
100,000
-3,447
| -3% | -$1.84M | 0.43% | 30 |
|
|
2023
Q2 | $54M | Buy |
103,447
+772
| +0.8% | +$417K | 0.44% | 31 |
|
|
2023
Q1 | $59.2M | Sell |
102,675
-593
| -0.6% | -$334K | 0.5% | 27 |
|
|
2022
Q4 | $56.9M | Buy |
103,268
+596
| +0.6% | +$316K | 0.51% | 27 |
|
|
2022
Q3 | $52.1M | Buy |
102,672
+2,811
| +3% | +$1.57M | 0.5% | 27 |
|
|
2022
Q2 | $54.3M | Sell |
99,861
-6,955
| -7% | -$3.83M | 0.51% | 27 |
|
|
2022
Q1 | $63.1M | Sell |
106,816
-5,875
| -5% | -$3.37M | 0.49% | 27 |
|
|
2021
Q4 | $75.2M | Buy |
112,691
+7,841
| +7% | +$4.9M | 0.55% | 22 |
|
|
2021
Q3 | $59.9M | Sell |
104,850
-3,940
| -4% | -$2.16M | 0.51% | 28 |
|
|
2021
Q2 | $54.9M | Buy |
108,790
+85,616
| +369% | +$40.4M | 0.44% | 33 |
|
|
2021
Q1 | $10.6M | Sell |
23,174
-1,030
| -4% | -$492K | 0.4% | 38 |
|
|
2020
Q4 | $11.3M | Sell |
24,204
-92
| -0.4% | -$43.1K | 0.43% | 36 |
|
|
2020
Q3 | $10.7M | Sell |
24,296
-654
| -3% | -$270K | 0.47% | 33 |
|
|
2020
Q2 | $9.04M | Sell |
24,950
-39,136
| -61% | -$13.1M | 0.42% | 40 |
|
|
2020
Q1 | $18.2M | Sell |
64,086
-1,843
| -3% | -$581K | 0.44% | 42 |
|
|
2019
Q4 | $21.4M | Buy |
65,929
+2,816
| +4% | +$854K | 0.39% | 48 |
|
|
2019
Q3 | $18.4M | Buy |
63,113
+8,742
| +16% | +$2.5M | 0.39% | 50 |
|
|
2019
Q2 | $16M | Buy |
54,371
+2,691
| +5% | +$741K | 0.37% | 43 |
|
|
2019
Q1 | $14.1M | Buy |
51,680
+1,571
| +3% | +$391K | 0.34% | 57 |
|
|
2018
Q4 | $11.2M | Sell |
50,109
-939
| -2% | -$220K | 0.32% | 62 |
|
|
2018
Q3 | $12.5M | Sell |
51,048
-1,254
| -2% | -$288K | 0.31% | 65 |
|
|
2018
Q2 | $10.8M | Sell |
52,302
-1,355
| -3% | -$288K | 0.26% | 67 |
|
|
2018
Q1 | $11.1M | Buy |
53,657
+2,246
| +4% | +$471K | 0.29% | 64 |
|
|
2017
Q4 | $9.76M | Buy |
51,411
+4,547
| +10% | +$871K | 0.26% | 71 |
|
|
2017
Q3 | $8.87M | Buy |
46,864
+1,943
| +4% | +$352K | 0.28% | 67 |
|
|
2017
Q2 | $7.84M | Buy |
44,921
+16,308
| +57% | +$2.74M | 0.26% | 73 |
|
|
2017
Q1 | $4.39M | Sell |
28,613
-4,953
| -15% | -$757K | 0.22% | 79 |
|
|
2016
Q4 | $4.74M | Buy |
33,566
+7,442
| +28% | +$1.1M | 0.21% | 81 |
|
|
2016
Q3 | $4.16M | Buy |
26,124
+72
| +0.3% | +$11.1K | 0.24% | 71 |
|
|
2016
Q2 | $4.1M | Buy |
26,052
+11,295
| +77% | +$1.67M | 0.24% | 71 |
|
|
2016
Q1 | $2.09M | Buy |
14,757
+3,759
| +34% | +$504K | 0.2% | 80 |
|
|
2015
Q4 | $1.56M | Sell |
10,998
-3,282
| -23% | -$438K | 0.19% | 79 |
|
|
2015
Q3 | $1.75M | Buy |
14,280
+450
| +3% | +$58.6K | 0.18% | 82 |
|
|
2015
Q2 | $1.79M | Buy |
13,830
+649
| +5% | +$84.6K | 0.18% | 90 |
|
|
2015
Q1 | $1.77M | Buy |
13,181
+3,209
| +32% | +$414K | 0.22% | 90 |
|
|
2014
Q4 | $1.25M | Sell |
9,972
-1,557
| -14% | -$189K | 0.2% | 99 |
|
|
2014
Q3 | $1.4M | Buy |
11,529
+344
| +3% | +$41.8K | 0.21% | 95 |
|
|
2014
Q2 | $1.32M | Buy |
11,185
+1,674
| +18% | +$197K | 0.2% | 95 |
|
|
2014
Q1 | $1.14M | Buy |
9,511
+610
| +7% | +$72.5K | 0.2% | 93 |
|
|
2013
Q4 | $991K | Buy |
+8,901
| New | +$885K | 0.17% | 115 |
|
Other funds holding TMO
Amalgamated Bank's TMO Position: Q2 2026 in Review
Amalgamated Bank reduced its Thermo Fisher Scientific (TMO) stake by 5.2% in Q2 2026, selling an estimated $1.72M and leaving 64,872 shares worth $32.5M. The position accounts for 0.22% of the portfolio, ranked #64.
Amalgamated Bank first reported a position in TMO in Q4 2013 and has held it in 51 quarters since. The position peaked at $75.2M in Q4 2021. 1,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Amalgamated Bank held 64,872 shares of Thermo Fisher Scientific worth $32.5M as of Q2 2026.
- Amalgamated Bank sold 3,575 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.72M.
- Thermo Fisher Scientific made up 0.22% of Amalgamated Bank's portfolio in Q2 2026, its #64 holding.
- Amalgamated Bank first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 51 quarters since.
- Amalgamated Bank's Thermo Fisher Scientific position peaked at $75.2M in Q4 2021.
- 1,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.